Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 2, Issue 3
August 2025
In Progress
Blood Neoplasia Cover Image for Volume 2, Issue 3

Volume 2 Issue 3 | Blood Neoplasia | American Society of Hematology

CLINICAL TRIALS AND OBSERVATIONS

Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysis
Clinical Trials & Observations
Aaron S. Rosenberg,Emanual Maverakis,Caitlin Costello,Elizabeth A. Brem,Matthew Joseph Wieduwilt,Guillaume Luxardi,Paul Kaesberg,Keon Abedi,Samantha Herbert,Joseph Tuscano
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Outcomes of myeloablative allogeneic hematopoietic cell transplantation with omidubicel vs alternative donor sources
Clinical Trials & Observations
Chenyu Lin,Smitha Sivaraman,Gautam Sajeev,Yan Song,Chunyi Xu,Chujun He,James E. Signorovitch,Heayoung Shin,Xiao-Ying Tang,Mei-Jie Zhang,Linda J. Burns,Ronit Simantov,Mitchell E. Horwitz
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

Lymphoid Neoplasia

Phase 2 trial of daratumumab, cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma
Edvan de Queiroz Crusoé,Joanna Suzana Leal Ribeiro dos Santos,Juliana de Andrade Santos,Herbert Henrique de Melo Santos,Allan de Souza Santos,Larissa Ferreira Lucas,Cristiane Almeida Requião de Pinna,Paula Nogueira Caldas Freire,Adriano Araujo de Jesus,Alessandro de Moura Almeida,Daniela Dourado Dutra,Marcos Fonseca Chaves,Jamile Souza Nicanor,Marco Aurelio Salvino,Maria da Gloria Bomfim Arruda,Vania Hungria,on behalf of GBRAM
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling
Ryan S. Humphrey,Seohee Nam,Dennis C. Wylie,Lauren I. R. Ehrlich
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
A novel cereblon variant with both exon 8 and 10 deletions in newly diagnosed and relapsed multiple myeloma
Yuan Xiao Zhu,Soumya Dutta,Gregory J. Ahmann,Laura Bruins,Mariano Arribas,Xianfeng Chen,Abhigna Polavarapu,Jonathan Chapman,Isaac Lopez,Marta Chesi,P. Leif Bergsagel,Abhishek Singharoy,Rafael Fonseca,Lisa M. Rimsza
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Ambroxol induces myeloma cell death by inhibiting autophagy
Yutaka Hattori,Hiromu Sugiyama,Yamato Miyashita,Shinsuke Shibata,Taiga Okaue,Yoshinao Matsumoto,Taketo Yamada,Tomofumi Yamamoto,Takashi Yamaguchi,Kohei Yamazaki,Hisako Kunieda,Hideyuki Saya,Maiko Matsushita
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma
Nikita K. Dave,Veronica Carvajal,Alex C. Watts,Jordan S. Carter,Michael Cook,Colin Thomas,Donald E. Tsai,Stephen J. Schuster,James N. Gerson,Stefan K. Barta,Jakub Svoboda,Elise A. Chong,Wei-Ting Hwang,Daniel J. Landsburg,Sunita D. Nasta
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience
Malin Hultcrantz,Andriy Derkach,Hani Hassoun,Neha Korde,Kylee Maclachlan,Sham Mailankody,Dhwani Patel,Urvi A. Shah,Carlyn R. Tan,David J. Chung,Oscar B. Lahoud,Heather J. Landau,Michael Scordo,Gunjan L. Shah,David Nemirovsky,Ross S. Firestone,Theresia Akhlaghi,Tala Shekarkhand,Sergio A. Giralt,Alexander M. Lesokhin,Saad Z. Usmani
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

MYELOID NEOPLASIA

Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm
Suravi Raychaudhuri,Ted A. Gooley,Allegra Rasmussen,Kim Quach,Eva Gill,Anna B. Halpern,Jacob S. Appelbaum,Cristina M. Ghiuzeli,Paul C. Hendrie,Ryan D. Cassaday,Roland B. Walter,Mary-Elizabeth M. Percival
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
TYK2 is essential for the therapeutic effect of IFN-α in Jak2V617F-induced murine myeloproliferative neoplasms
Yuki Tahira,Kotaro Shide,Takuro Kameda,Taisuke Uchida,Ayako Kamiunten,Keiichi Akizuki,Yoko Kubuki,Masayoshi Karasawa,Ryoma Ikeda,Kengo Matsumoto,Jie Bai,Minoru Terashima,Koji Kato,Tomofumi Uto,Tomohiro Fukaya,Shuya Mitoma,Katsuaki Sato,Yudai Uehira,Hiroaki Ueno,Goro Sashida,Hideki Yamaguchi,Kazuya Shimoda
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis
Malin Sveijer,Désirée Gavhed,Helena Hertzberg,Eric Zander,Jan-Inge Henter,Tatiana von Bahr Greenwood
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

RESEARCH LETTER

Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies
Emil Ramsø Kyvsgaard,Trine Lønbo Grantzau,Mia Dahl Sørensen,Michael Boe Møller,Lene Dissing Sjø,Morten Grauslund,Trine Trab,Linea Cecilie Melchior,Lærke Sloth Andersen,Caroline Riley,Carsten U. Niemann,Jacob Haaber,Thomas Stauffer Larsen,Michael Roost Clausen,Kirsten Grønbæk,Martin Hutchings,Simon Husby
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab
Charles Pei,Zeinab El Boghdadly,Lisa Blackburn,Nidhi Sharma,Naresh Bumma,Abdullah M. Khan,Srinivas Devarakonda,Elvira Umyarova,Don Benson,Ashley Rosko,Francesca Cottini
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Magnetic resonance spectroscopy–based detection of response to therapy targeting glutaminolysis in lymphoma
Kavindra Nath,Pradeep K. Gupta,Shengchun Wang,Alexander A. Shestov,Neil Sen,Shilpa Rao,Stepan Orlovskiy,Cosimo Lobello,David Rushmore,Fernando Arias-Mendoza,Johnvesly Basappa,David S. Nelson,Mariusz A. Wasik
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
All Issues

Advertisement intended for health care professionals

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 

Advertisement intended for health care professionals

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals